P3.02b-086 ASP8273 Tolerability and Antitumor Activity in TKI-Naïve Japanese Subjects with EGFRmut+ NSCLC: Preliminary Results: Topic: EGFR Clinical
Makoto Nishio,Koichi Azuma,Hidetoshi Hayashi,Toyoaki Hida,Akira Inoue,Yasuo Iwamoto,Satoshi Ikeda,Katsuyuki Kiura,Miyako Satouchi,Shunichi Sugawara,Koji Takeda,Desai Bhardwaj,Anne Keating,Kanji Komatsu,Maiko Morishita,Kentaro Takeda,Satoshi Morita,Masahiro Fukuoka,Kazuhiko Nakagawa Journal of Thoracic Oncology（2017）
AI 理解论文
溯源树
样例
